Sanat Chattopadhyay is the Executive Vice President and President of the Merck Manufacturing Division at Merck & Co., Inc. With a robust background in pharmaceuticals, Chattopadhyay has been instrumental in steering Merck's manufacturing operations towards innovation and efficiency. He joined Merck in 2016, bringing with him extensive experience from his previous roles at other major pharmaceutical companies, including Pfizer and Wyeth. At Merck, Chattopadhyay oversees the company's global manufacturing operations, ensuring the production of high-quality pharmaceuticals that meet stringent regulatory standards. Under his leadership, Merck has made significant strides in adopting advanced technologies and sustainable practices in its manufacturing processes. His strategic vision has been pivotal in enhancing Merck's supply chain resilience, especially during global challenges such as the COVID-19 pandemic. Prior to his current role, Chattopadhyay held various leadership positions within Merck, which have equipped him with a comprehensive understanding of the company's operations and culture. Chattopadhyay's career in the pharmaceutical industry spans over three decades, during which he has earned a reputation for driving operational excellence and fostering a culture of continuous improvement. His contributions have not only bolstered Merck's position in the market but have also had a profound impact on the broader pharmaceutical industry. Chattopadhyay's commitment to innovation and sustainability continues to shape Merck's future, as he leads the company towards new heights in global healthcare manufacturing.